Editorial: Integrated systems genomic approaches for characterizing uncharacterized proteins.
Ontology highlight
ABSTRACT:
SUBMITTER: Valadi J
PROVIDER: S-EPMC9513579 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
Publications
Editorial: Integrated systems genomic approaches for characterizing uncharacterized proteins.
Valadi Jayaraman J Sundararajan Vijayaraghava Seshadri VS Bandapalli Obul Reddy OR Benso Alfredo A Suravajhala Prashanth P
Frontiers in genetics 20220913
Similar Datasets
Project description:A systematic comparative genomic analysis of all archaeal membrane proteins that have been projected to the last archaeal common ancestor gene set led to the identification of several novel components of predicted secretion, membrane remodeling, and protein glycosylation systems. Among other findings, most crenarchaea have been shown to encode highly diverged orthologs of the membrane insertase YidC, which is nearly universal in bacteria, eukaryotes, and euryarchaea. We also identified a vast family of archaeal proteins, including the C-terminal domain of N-glycosylation protein AglD, as membrane flippases homologous to the flippase domain of bacterial multipeptide resistance factor MprF, a bifunctional lysylphosphatidylglycerol synthase and flippase. Additionally, several proteins were predicted to function as membrane transporters. The results of this work, combined with our previous analyses, reveal an unexpected diversity of putative archaeal membrane-associated functional systems that remain to be functionally characterized. A more general conclusion from this work is that the currently available collection of archaeal (and bacterial) genomes could be sufficient to identify (almost) all widespread functional modules and develop experimentally testable predictions of their functions.
| S-EPMC5898192 | biostudies-literature
Project description:In recent years, the marine environment has been the subject of increasing attention from biotechnological and pharmaceutical industries as a valuable and promising source of novel bioactive compounds. Marine biodiscovery programmes have begun to reveal the extent of novel compounds encoded within the enormous bacterial richness and diversity of the marine ecosystem. A combination of unique physicochemical properties and spatial niche-specific substrates, in wide-ranging and extreme habitats, underscores the potential of the marine environment to deliver on functionally novel biocatalytic activities. With the growing need for green alternatives to industrial processes, and the unique transformations which nature is capable of performing, marine biocatalysts have the potential to markedly improve current industrial pipelines. Furthermore, biocatalysts are known to possess chiral selectivity and specificity, a key focus of pharmaceutical drug design. In this review, we discuss how the explosion in genomics based sequence analysis, allied with parallel developments in synthetic and molecular biology, have the potential to fast-track the discovery and subsequent improvement of a new generation of marine biocatalysts.
| S-EPMC4810074 | biostudies-literature
Project description: Not available
| S-EPMC8450575 | biostudies-literature
Project description: Not available
| S-EPMC10728862 | biostudies-literature
Project description:One Health (OH), EcoHealth (EH), and Planetary Health (PH) share an interest in transdisciplinary efforts that bring together scientists, citizens, government and private sectors to implement contextualized actions that promote adaptive health management across human, animal and ecosystem interfaces. A key operational element underlying these Integrated Approaches to Health (IAH) is use of Systems Thinking as a set of tools for integration. In this paper we discuss the origins and epistemology of systems thinking and argue that participatory modeling, informed by both systems theory and expertise in facilitating engagement and social learning, can help ground IAH theoretically and support its development. Participatory modeling is iterative and adaptive, which is necessary to deal with complexity in practice. Participatory modeling (PM) methods actively involve affected interests and stakeholders to ground the field of inquiry in a specific social-ecological context. Furthermore, PM processes act to reconcile the diverse understandings of the empirical world that stem from divergent discipline and community viewpoints. In this perspective article, we argue that PM can support systems thinking in practice and is essential for IAH implementation. Accordingly we invite PH, OH, and EH practitioners to systematically incorporate specialists in systems science and social engagement and facilitation. This will enable the appropriate contextualization of research practice and interventions, and ensure a balanced representation of the roles and relationships of medical, biological, mathematical, and social disciplines. For completeness, funding schemes supporting IAH need to follow the same iterative, adaptive, and participative processes to accompany IAH projects throughout their implementation.
| S-EPMC6305083 | biostudies-other
Project description:The genetic architecture underlying the heritability of cardiovascular disease is incompletely understood. Metabolomics is an emerging technology platform that has shown early success in identifying biomarkers and mechanisms of common chronic diseases. Integration of metabolomics, genetics, and other omics platforms in a systems biology approach holds potential for elucidating novel genetic markers and mechanisms for cardiovascular disease. We review important studies that have used metabolomic profiling in cardiometabolic diseases, approaches for integrating metabolomics with genetics and other molecular profiling platforms, and key studies showing the potential for such studies in deciphering cardiovascular disease genetics, biomarkers, and mechanisms.
| S-EPMC4408557 | biostudies-literature
Project description:Metabolic engineering aims to maximize the production of bio-economically important substances (compounds, enzymes, or other proteins) through the optimization of the genetics, cellular processes and growth conditions of microorganisms. This requires detailed understanding of underlying metabolic pathways involved in the production of the targeted substances, and how the cellular processes or growth conditions are regulated by the engineering. To achieve this goal, a large system of experimental techniques, compound libraries, computational methods and data resources, including the multi-omics data, are used. The recent advent of multi-omics systems biology approaches significantly impacted the field by opening new avenues to perform dynamic and large-scale analyses that deepen our knowledge on the manipulations. However, with the enormous transcriptomics, proteomics and metabolomics available, it is a daunting task to integrate the data for a more holistic understanding. Novel data mining and analytics approaches, including Artificial Intelligence (AI), can provide breakthroughs where traditional low-throughput experiment-alone methods cannot easily achieve. Here, we review the latest attempts of combining systems biology and AI in metabolic engineering research, and highlight how this alliance can help overcome the current challenges facing industrial biotechnology, especially for food-related substances and compounds using microorganisms.
| S-EPMC7546651 | biostudies-literature
Project description:SARS-CoV-2 is mutating and creating divergent variants by altering the composition of essential constituent proteins. Pharmacologically, it is crucial to understand the diverse mechanism of mutations for stable vaccine or anti-viral drug design. Our current study concentrates on all the constituent proteins of 469 SARS-CoV-2 genome samples, derived from Indian patients. However, the study may easily be extended to the samples across the globe. We perform clustering analysis towards identifying unique variants in each of the SARS-CoV-2 proteins. A total of 536 mutated positions within the coding regions of SARS-CoV-2 proteins are detected among the identified variants from Indian isolates. We quantify mutations by focusing on the unique variants of each SARS-CoV-2 protein. We report the average number of mutation per variant, percentage of mutated positions, synonymous and non-synonymous mutations, mutations occurring in three codon positions and so on. Our study reveals the most susceptible six (06) proteins, which are ORF1ab, Spike (S), Nucleocapsid (N), ORF3a, ORF7a, and ORF8. Several non-synonymous substitutions are observed to be unique in different SARS-CoV-2 proteins. A total of 57 possible deleterious amino acid substitutions are predicted, which may impact on the protein functions. Several mutations show a large decrease in protein stability and are observed in putative functional domains of the proteins that might have some role in disease pathogenesis. We observe a good number of physicochemical property change during above deleterious substitutions.
| S-EPMC7893251 | biostudies-literature
Project description: Not available
| S-EPMC7399369 | biostudies-literature
Project description:Left ventricular mass (LVM) and cardiac gene expression are complex traits regulated by factors both intrinsic and extrinsic to the heart. To dissect the major determinants of LVM, we combined expression quantitative trait locus1 and quantitative trait transcript (QTT) analyses of the cardiac transcriptome in the rat. Using these methods and in vitro functional assays, we identified osteoglycin (Ogn) as a major candidate regulator of rat LVM, with increased Ogn protein expression associated with elevated LVM. We also applied genome-wide QTT analysis to the human heart and observed that, out of 22,000 transcripts, OGN transcript abundance had the highest correlation with LVM. We further confirmed a role for Ogn in the in vivo regulation of LVM in Ogn knockout mice. Taken together, these data implicate Ogn as a key regulator of LVM in rats, mice and humans, and suggest that Ogn modifies the hypertrophic response to extrinsic factors such as hypertension and aortic stenosis.
| S-EPMC2742198 | biostudies-literature